 
    
  
  
  Could Darling Become One? Shares Jump on an Ingredients-Fueled Beat
From fryer oil to future fuel: DAR beat on sales, guided core EBITDA to $875–900M, and is monetizing PTCs while prepping SAF scale-up. Fun + smart breakdown with TL;DR & FAQs.
 
    
  
  
  Funds and Analysts Love BioMarin Pharmaceutical (BMRN), A Rare Combo of Value and Growth Fighting Also Rare Genetic Diseases. Should You?
BioMarin is that rare biotech: profits, pipeline, and price discipline. VOXZOGO grows, margins expand, and catalysts stack—at a surprisingly modest valuation.
 
    
  
  
  Year-Old CEO Could Start Making an Impact: Can Teladoc (TDOC) Reboot Growth, Turn a Profit, and Send Its Stock Back to the Moon?
Teladoc Health is down 97% from ATH — but Citron says Livongo is booming, institutions are buying, and the CEO just hit his one-year mark. Bargain bin or value trap?
 
    
  
  
  Target: Can the New CEO Finally Attract Bull’s Eye?
Target stock has lost 2/3 of its value since 2021. With a new CEO, strong dividends, and institutional support, is this retailer ready to bounce back?
 
    
  
  
  Duolingo (DUOL): A Compelling Growth Investment and A Buy in Any Language?
Duolingo (DUOL) is flying high with 41% revenue growth, record profits, and a chess course attracting millions. Institutions can’t get enough. But is the stock a smart buy—or just owl-wardly expensive?
 
    
  
  
  Peloton Interactive (PTON): Can This Fitness Unicorn Get Its Groove Back?
Peloton (PTON) is no longer just a bike company—it’s trying to pivot into a full wellness platform. Institutions are buying, shorts are circling, and the new CEO is bringing Apple/Ford cred. But can Peloton spin its way back to growth, or is this ride still too risky?
 
    
  
  
  Teladoc: Still Waiting for Insiders and Hedge Funds to Swipe Right
TDOC is back in the spotlight with a 20% gain—but is the recovery real? From big losses to insider silence, Teladoc’s journey is part growth story, part therapy session. We break it down (with emojis and a side of humor).
 
    
  
  
  Match Group (MTCH) Update: CEO Keeps Swiping Buy + Hinge Still Crushing It
Spencer Rascoff is swiping right on Match Group. With Hinge outpacing Tinder, free cash flow flowing, and big-name funds saying “I do,” is this the rebound stock your portfolio’s been hoping for?
 
    
  
  
  Disney (DIS): Even the Stock Has Its Own Kind of Magic! ✨📈🏰
Wall Street's smiling on Disney (DIS), and with good reason. Streaming is profitable, ESPN is evolving, and the parks are buzzing. But is the stock a sleeping beauty or ready to soar? 🏰🔍
 
    
  
  
  🖱️ I Searched "Buy" and Found Google!
Alphabet (GOOG) keeps breaking barriers in cloud, AI, and advertising—but its stock trades at a surprisingly low valuation. With net income up 28% and EPS rising 31%, it’s time to ask: is Google the value stock of the tech world?
Quick links
                      
                        Search
                      
                        Privacy Policy
                      
                        Refund Policy
                      
                        Shipping Policy
                      
                        Terms of Service
                      
                    
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
